Quick Answer
Tonix Pharmaceuticals Holding Corp. reported Stockholders Equity of $245.15 million for fiscal year 2025.
Tonix Pharmaceuticals Holding Corp. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $245.15M | +75.7% |
| 2024 | $139.56M | +32.3% |
| 2023 | $105.53M | -49.1% |
| 2022 | $207.18M | -5.3% |
| 2021 | $218.72M | +149.5% |
| 2020 | $87.65M | +830.7% |
| 2019 | $9.42M | -60.2% |
| 2018 | $23.66M | -3.9% |
| 2017 | $24.62M | -2.9% |
| 2016 | $25.36M | -37.0% |
| 2015 | $40.26M | +11.6% |
| 2014 | $36.09M | +454.2% |
| 2013 | $6.51M | +579.0% |
| 2012 | $959.0K | +139.1% |
| 2011 | -$2.45M | -1302.3% |
| 2010 | -$175.0K | +67.4% |
| 2009 | -$537.0K | +1.5% |
| 2008 | -$545.0K | -31.3% |
| 2007 | -$415.0K | — |
| 2007 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $231.14M | +211.5% | +37.6% |
| June 30, 2025 | $168.00M | +299.0% | -6.9% |
| March 31, 2025 | $180.40M | +66.8% | +29.3% |
| December 31, 2024 | $139.56M | +32.3% | +88.1% |
| September 30, 2024 | $74.21M | -38.6% | +76.3% |
| June 30, 2024 | $42.10M | -70.0% | -61.1% |
| March 31, 2024 | $108.14M | -34.6% | +2.5% |
| December 31, 2023 | $105.53M | -49.1% | -12.7% |
- Tonix Pharmaceuticals Holding Corp. showed an increase of +75.7% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from Tonix Pharmaceuticals Holding Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: